Tropical Bacterial Gastrointestinal Infections

Sadia Shakoor; Anita K.M. Zaidi; Rumina Hasan

doi:10.1016/j.idc.2012.02.002

Tropical Bacterial Gastrointestinal Infections

Research output: Contribution to journal › Review article › peer-review

13 Citations (Scopus)

Abstract

The bacterial gastrointestinal infections cholera, salmonellosis, shigellosis, campylobacteriosis, and diarrheagenic Escherichia coli are prevalent in tropical regions. These diseases impose an immense cost and contribute significantly to childhood morbidity and mortality. Management is hampered by limited access to diagnostic facilities and by antimicrobial drug resistance. Rapid point-of-care assays aim to reduce treatment delay and encourage rational use of antimicrobial agents. Control through safe drinking water, good sanitation, and vaccination against typhoid and cholera in high-risk populations is recommended. Vaccines against other Shigella and diarrheagenic E coli infections are under development.

Original language	English (UK)
Pages (from-to)	437-453
Number of pages	17
Journal	Infectious Disease Clinics of North America
Volume	26
Issue number	2
DOIs	https://doi.org/10.1016/j.idc.2012.02.002
Publication status	Published - Jun 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 6 Clean Water and Sanitation

Keywords

Antimicrobial resistance
Cholera
Diarrhea
Enteric fever
Enteric vaccines
Salmonella
Shigella
Tropical infections

Access to Document

10.1016/j.idc.2012.02.002

Cite this

@article{f1e584abb33a4b8bb58ce6e0cb627d02,

title = "Tropical Bacterial Gastrointestinal Infections",

abstract = "The bacterial gastrointestinal infections cholera, salmonellosis, shigellosis, campylobacteriosis, and diarrheagenic Escherichia coli are prevalent in tropical regions. These diseases impose an immense cost and contribute significantly to childhood morbidity and mortality. Management is hampered by limited access to diagnostic facilities and by antimicrobial drug resistance. Rapid point-of-care assays aim to reduce treatment delay and encourage rational use of antimicrobial agents. Control through safe drinking water, good sanitation, and vaccination against typhoid and cholera in high-risk populations is recommended. Vaccines against other Shigella and diarrheagenic E coli infections are under development.",

keywords = "Antimicrobial resistance, Cholera, Diarrhea, Enteric fever, Enteric vaccines, Salmonella, Shigella, Tropical infections",

author = "Sadia Shakoor and Zaidi, \{Anita K.M.\} and Rumina Hasan",

year = "2012",

month = jun,

doi = "10.1016/j.idc.2012.02.002",

language = "English (UK)",

volume = "26",

pages = "437--453",

journal = "Infectious Disease Clinics of North America",

issn = "0891-5520",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Tropical Bacterial Gastrointestinal Infections

AU - Shakoor, Sadia

AU - Zaidi, Anita K.M.

AU - Hasan, Rumina

PY - 2012/6

Y1 - 2012/6

N2 - The bacterial gastrointestinal infections cholera, salmonellosis, shigellosis, campylobacteriosis, and diarrheagenic Escherichia coli are prevalent in tropical regions. These diseases impose an immense cost and contribute significantly to childhood morbidity and mortality. Management is hampered by limited access to diagnostic facilities and by antimicrobial drug resistance. Rapid point-of-care assays aim to reduce treatment delay and encourage rational use of antimicrobial agents. Control through safe drinking water, good sanitation, and vaccination against typhoid and cholera in high-risk populations is recommended. Vaccines against other Shigella and diarrheagenic E coli infections are under development.

AB - The bacterial gastrointestinal infections cholera, salmonellosis, shigellosis, campylobacteriosis, and diarrheagenic Escherichia coli are prevalent in tropical regions. These diseases impose an immense cost and contribute significantly to childhood morbidity and mortality. Management is hampered by limited access to diagnostic facilities and by antimicrobial drug resistance. Rapid point-of-care assays aim to reduce treatment delay and encourage rational use of antimicrobial agents. Control through safe drinking water, good sanitation, and vaccination against typhoid and cholera in high-risk populations is recommended. Vaccines against other Shigella and diarrheagenic E coli infections are under development.

KW - Antimicrobial resistance

KW - Cholera

KW - Diarrhea

KW - Enteric fever

KW - Enteric vaccines

KW - Salmonella

KW - Shigella

KW - Tropical infections

UR - https://www.scopus.com/pages/publications/84861476206

U2 - 10.1016/j.idc.2012.02.002

DO - 10.1016/j.idc.2012.02.002

M3 - Review article

C2 - 22632648

AN - SCOPUS:84861476206

SN - 0891-5520

VL - 26

SP - 437

EP - 453

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

IS - 2

ER -

Tropical Bacterial Gastrointestinal Infections

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this